Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Oct 5, 2026
Purchase
Shares
1,694
Price
$2.06
Total Value
$3.49K
Shares Held After
2,858,657
% of Holdings
0.1%
Oct 5, 2026
Purchase
Shares
18,182
Price
$1.33
Total Value
$24.18K
Shares Held After
935,021
% of Holdings
1.9%
Oct 2, 2026
Purchase
Shares
20,000
Price
$2.07
Total Value
$41.37K
Shares Held After
2,856,963
% of Holdings
0.7%
Oct 2, 2026
Purchase
Shares
8,307
Price
$1.33
Total Value
$11.05K
Shares Held After
916,839
% of Holdings
0.9%
Oct 2, 2026
Purchase
Shares
10,000
Price
$1.46
Total Value
$14.60K
Shares Held After
1,590,294
% of Holdings
0.6%
Oct 1, 2026
Purchase
Shares
38,796
Price
$2.04
Total Value
$78.96K
Shares Held After
2,836,963
% of Holdings
1.4%
Oct 1, 2026
Purchase
Shares
16,431
Price
$1.33
Total Value
$21.85K
Shares Held After
908,532
% of Holdings
1.8%
Oct 1, 2026
Purchase
Shares
10,000
Price
$1.42
Total Value
$14.20K
Shares Held After
1,580,294
% of Holdings
0.6%

Compass Therapeutics, Inc. (CMPX)

Lerner Neil — Chief Accounting Officer
Oct 1, 2026
Purchase
Shares
20,000
Price
$0.92
Total Value
$18.40K
Shares Held After
420,000
% of Holdings
4.8%

Lipocine Inc. (LPCN)

Higuchi John W. — Director
Sep 30, 2026
Purchase
Shares
15,970
Price
$2.23
Total Value
$35.61K
Shares Held After
241,365
% of Holdings
6.6%
Sep 30, 2026
Purchase
Shares
30,000
Price
$37.38
Total Value
$1.12M
Shares Held After
49,923
% of Holdings
60.1%

Xenon Pharmaceuticals Inc. (XENE)

Kelly Thomas Patrick — Chief Financial Officer
Sep 30, 2026
Purchase
Shares
15,000
Price
$37.32
Total Value
$559.74K
Shares Held After
15,000
% of Holdings
100.0%
Sep 30, 2026
Purchase
Shares
100,000
Price
$0.92
Total Value
$92.00K
Shares Held After
1,337,964
% of Holdings
7.5%

Anixa Biosciences Inc (ANIX)

Catelani Michael — President, COO,&CFO
Sep 30, 2026
Purchase
Shares
5,500
Price
$2.84
Total Value
$15.62K
Shares Held After
50,000
% of Holdings
11.0%
Sep 29, 2026
Purchase
Shares
200,000
Price
$0.05
Total Value
$10.00K
Shares Held After
200,000
% of Holdings
100.0%

Helus Pharma Inc. (HELP)

Cavers Greg — Chief Financial Officer
Sep 29, 2026
Purchase
Shares
3,000
Price
$12.91
Total Value
$38.73K
Shares Held After
3,000
% of Holdings
100.0%

Lipocine Inc. (LPCN)

Higuchi John W. — Director
Sep 29, 2026
Purchase
Shares
9,037
Price
$2.15
Total Value
$19.43K
Shares Held After
225,395
% of Holdings
4.0%
Sep 29, 2026
Purchase
Shares
7,849
Price
$2.09
Total Value
$16.40K
Shares Held After
2,798,167
% of Holdings
0.3%
Sep 29, 2026
Purchase
Shares
206,813
Price
$0.90
Total Value
$186.13K
Shares Held After
1,237,964
% of Holdings
16.7%

BioCardia, Inc. (BCDA)

Altman Peter — Director
Sep 29, 2026
Purchase
Shares
1,000
Price
$1.03
Total Value
$1.03K
Shares Held After
384,885
% of Holdings
0.3%
Sep 29, 2026
Purchase
Shares
162,000
Price
$8.68
Total Value
$1.41M
Shares Held After
214,000
% of Holdings
75.7%
Sep 29, 2026
Purchase
Shares
1,416
Price
$85.89
Total Value
$121.61K
Shares Held After
20,191,214
% of Holdings
0.0%
Sep 29, 2026
Purchase
Shares
84
Price
$85.89
Total Value
$7.21K
Shares Held After
1,669,727
% of Holdings
0.0%
Sep 29, 2026
Purchase
Shares
20,031
Price
$85.40
Total Value
$1.71M
Shares Held After
20,189,798
% of Holdings
0.1%
Sep 29, 2026
Purchase
Shares
1,195
Price
$85.40
Total Value
$102.06K
Shares Held After
1,669,643
% of Holdings
0.1%
Sep 29, 2026
Purchase
Shares
10,381
Price
$84.24
Total Value
$874.52K
Shares Held After
20,169,767
% of Holdings
0.1%
Sep 29, 2026
Purchase
Shares
619
Price
$84.24
Total Value
$52.15K
Shares Held After
1,668,448
% of Holdings
0.0%
Sep 29, 2026
Purchase
Shares
5,000
Price
$1.04
Total Value
$5.20K
Shares Held After
42,000
% of Holdings
11.9%
Version: v26.10.4